Articles

Thermo Fisher Scientific announces collaboration to establish new Tokyo Biomarker Research Center

Efforts teams Thermo’s BRIMS Center with Tokyo Medical University Hospital and Lund University in Sweden
Written byJeffrey Bouley
| 2 min read

SAN JOSE, Calif.—Looking for a chance to introduce mass spectrometry-based workflows and technologies into Japan to advance personalized medicine, Thermo Fisher Scientific Inc. has announced what it is calling "a landmark collaboration" between its Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center, Tokyo Medical University Hospital and Lund University in Sweden. The efforts is aimed at creating the Tokyo Biomarker Research Center, which will focus on biomarker discovery and quantification, disease mechanisms, therapeutic drug monitoring and disease pathophysiology.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.